Molecular Analysis of Patients With Neuromuscular Disease
Molecular Analysis of Patients With Neuromuscular Disease
Recruiting · NCT00390104 · Registry updated 2023-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Molecular Analysis of Patients With Neuromuscular Disease | Atrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscle Weakness, Muscular Disorders, Atrophic, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, X-linked disease, hereditary disease, limb-girdle muscular dystrophy, muscle tissue disorder, muscular atrophy, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Not stated | 2023-04-24 | NCT00390104 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Children's Hospital | 238 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |